A
ABL Bio Inc
KOSDAQ:298380
ABL Bio Inc
KOSDAQ:298380
Price:
44 250
KRW
29.96%
Market Closed
Market Cap:
2.1T
KRW
Balance Sheet
Balance Sheet Decomposition
ABL Bio Inc
ABL Bio Inc
| Current Assets | 144.2B |
| Cash & Short-Term Investments | 140.7B |
| Receivables | 1.2B |
| Other Current Assets | 2.3B |
| Non-Current Assets | 87.8B |
| PP&E | 85.4B |
| Intangibles | 2.4B |
| Other Non-Current Assets | 28m |
Balance Sheet
ABL Bio Inc
ABL Bio Inc
Currency: KRW
Millions
Annual
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
5 340
|
1 996
|
122 035
|
91 146
|
40 658
|
21 589
|
25 136
|
28 064
|
56 289
|
|
| Cash Equivalents |
5 340
|
1 996
|
122 035
|
91 146
|
40 658
|
21 589
|
25 136
|
28 064
|
56 289
|
|
| Short-Term Investments |
0
|
7 174
|
32 865
|
42 141
|
29 733
|
22 058
|
53 174
|
43 085
|
84 371
|
|
| Total Receivables |
77
|
10
|
5 745
|
755
|
1 394
|
208
|
573
|
2 003
|
1 223
|
|
| Accounts Receivables |
0
|
0
|
5 386
|
9
|
865
|
3
|
4
|
51
|
617
|
|
| Other Receivables |
0
|
0
|
359
|
746
|
2 259
|
205
|
569
|
1 952
|
606
|
|
| Other Current Assets |
279
|
257
|
446
|
614
|
135
|
1 618
|
1 652
|
2 386
|
2 268
|
|
| Total Current Assets |
5 695
|
9 437
|
161 091
|
134 657
|
71 920
|
45 472
|
80 535
|
75 539
|
144 151
|
|
| PP&E Net |
1 483
|
1 924
|
2 699
|
5 042
|
4 065
|
3 304
|
6 713
|
76 035
|
85 406
|
|
| PP&E Gross |
1 483
|
1 924
|
2 699
|
5 042
|
4 065
|
3 304
|
6 713
|
76 035
|
85 406
|
|
| Accumulated Depreciation |
155
|
521
|
1 072
|
2 513
|
4 426
|
6 251
|
6 230
|
8 169
|
8 219
|
|
| Intangible Assets |
270
|
369
|
507
|
2 753
|
2 708
|
2 556
|
2 610
|
2 534
|
2 390
|
|
| Long-Term Investments |
0
|
8 512
|
4 371
|
0
|
20 620
|
13 503
|
93 634
|
2 743
|
0
|
|
| Other Long-Term Assets |
83
|
128
|
200
|
450
|
582
|
617
|
1 689
|
3 294
|
28
|
|
| Total Assets |
7 530
N/A
|
20 370
+171%
|
168 869
+729%
|
142 903
-15%
|
99 894
-30%
|
65 453
-34%
|
185 181
+183%
|
160 144
-14%
|
231 976
+45%
|
|
| Liabilities | ||||||||||
| Accrued Liabilities |
11
|
7
|
13
|
30
|
98
|
16
|
184
|
165
|
398
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43 000
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
801
|
940
|
502
|
1 167
|
784
|
637
|
|
| Other Current Liabilities |
292
|
1 337
|
11 573
|
8 496
|
6 930
|
8 232
|
70 821
|
40 810
|
19 326
|
|
| Total Current Liabilities |
303
|
1 344
|
11 586
|
9 327
|
7 969
|
8 750
|
72 172
|
41 760
|
63 361
|
|
| Long-Term Debt |
2 327
|
7 628
|
0
|
1 079
|
555
|
72
|
40 669
|
43 154
|
26
|
|
| Other Liabilities |
16 999
|
97 353
|
321
|
488
|
706
|
677
|
2 826
|
1 152
|
1 309
|
|
| Total Liabilities |
19 629
N/A
|
106 325
+442%
|
11 907
-89%
|
10 895
-8%
|
9 230
-15%
|
9 500
+3%
|
115 667
+1 118%
|
86 065
-26%
|
64 696
-25%
|
|
| Equity | ||||||||||
| Common Stock |
96
|
96
|
22 294
|
22 652
|
23 123
|
23 562
|
23 894
|
23 946
|
27 030
|
|
| Retained Earnings |
13 685
|
88 489
|
205 693
|
243 285
|
299 059
|
342 535
|
339 134
|
342 345
|
398 304
|
|
| Additional Paid In Capital |
1 489
|
2 437
|
332 918
|
334 393
|
342 465
|
348 732
|
361 173
|
363 760
|
510 998
|
|
| Other Equity |
0
|
0
|
7 443
|
18 248
|
24 136
|
26 194
|
23 580
|
28 718
|
27 556
|
|
| Total Equity |
12 099
N/A
|
85 955
-610%
|
156 962
N/A
|
132 008
-16%
|
90 665
-31%
|
55 953
-38%
|
69 513
+24%
|
74 079
+7%
|
167 280
+126%
|
|
| Total Liabilities & Equity |
7 530
N/A
|
20 370
+171%
|
168 869
+729%
|
142 903
-15%
|
99 894
-30%
|
65 453
-34%
|
185 181
+183%
|
160 144
-14%
|
231 976
+45%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
19
|
19
|
45
|
45
|
46
|
47
|
48
|
48
|
48
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
